Intrinsic Value
Aclaris Therapeutics, Inc. (ACRS)
$1.24
+0.01 (+0.81%)
Enterprise Value | -197,851.93 |
---|---|
Net Debt | -39.45 |
Equity Value | -197,812.48 |
Shares Outstanding | 69.81 |
Equity Value Per Share | -2,833.63 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt